| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Creative Medical Technology Holdings, Inc.
13D
CELZ · 22529Y408
|
13.7% |
10/1/2026
Event 9/24/2026
|
||||
| Timothy Warbington | 13.7% | |||||
| Creative Acquisition Corp. | 13.2% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.